Showing results (51-60 of 389) with videos related to

Sort By:
Pageof 39
Oncology and Therapy|October 13, 2025
The Management of ER-Low, HER2-Negative Breast Cancer in the United Kingdom: A Survey of Current Clinical PracticeKa Chai Sit, Alison M Berner, Conor McCahill, et al.
Oncology and Therapy|September 14, 2025
First-Line Tislelizumab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: PD-L1 ≥ 50% Subgroup Analysis from the RATIONALE-304 TrialShun Lu, Jie Wang, Yan Yu, et al.
Oncology and Therapy|August 4, 2025
Progression-Free Survival Under Immune Checkpoint Inhibitors for Metastatic Non-Small-Cell Lung Cancer: A Retrospective Cohort StudyPaul Boré, Margaux Geier, Loïc Campion, et al.
Oncology and Therapy|September 11, 2025
A Practical Approach to Understanding Real-World Study Methodology in Cancer Research: A VodcastAdam Brufsky, Winson Cheung, Joanne C Ryan
Oncology and Therapy|May 15, 2021
A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination TherapyChin-Chou Wang, Li-Chung Chiu, Pi-Hung Tung, et al.
Oncology and Therapy|July 24, 2025
Pharmacoeconomic Analysis of Brigatinib versus Alectinib in First‑Line Treatment of Anaplastic Lymphoma Kinase‑Positive Advanced Non‑Small‑Cell Lung Cancer in ChinaQingqing Chai, Congling Gu, Luis Hernandez, et al.
Oncology and Therapy|July 16, 2025
Clinical Outcome of Febrile Neutropenia and Associated Factors Among Adult Patients with Cancer Treated at Ethiopian Oncology Centers: A Retrospective Observational StudySamuel Agegnew Wondm, Getachew Yitayew Tarekegn, Fisseha Nigussie Dagnew, et al.
Oncology and Therapy|December 17, 2025
Activation of SV2B Inhibits Matrix-Stiffness-Induced Tumorigenesis and EMT in Glioma via FAK/PI3K/AKT Signaling PathwayDengzhen Ma, Yunda Wang, Longyu Sang, et al.
Oncology and Therapy|December 16, 2025
Social Determinants of Health in Metastatic Breast Cancer Care: A Podcast Exploring Challenges and Opportunities in the United States and CanadaMonique Gary, Karen Gelmon, Joanne C Ryan
Oncology and Therapy|February 14, 2025
Real-World Observational Study of Incidence and Outcomes in an HR+/HER2- Early Breast Cancer Population with High-Risk of Recurrence in FinlandRavinder Singh, Samuli Tuominen, Mariann I Lassenius, et al.
Pageof 39